After the pandemic: perspectives on the future trajectory of COVID-19 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-07-08

AUTHORS

Amalio Telenti, Ann Arvin, Lawrence Corey, Davide Corti, Michael S. Diamond, Adolfo García-Sastre, Robert F. Garry, Edward C. Holmes, Phillip S. Pang, Herbert W. Virgin

ABSTRACT

There is a realistic expectation that the global effort in vaccination will bring the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control. Nonetheless, uncertainties remain about the type of long-term association that the virus will establish with the human population and, in particular, whether coronavirus disease 2019 (COVID-19) will become an endemic disease. Although the trajectory is difficult to predict, the conditions, concepts and variables that influence this transition can be anticipated. Persistence of SARS-CoV-2 as an endemic virus, perhaps with seasonal epidemic peaks, may be fuelled by pockets of susceptible individuals and waning immunity after infection or vaccination, changes in the virus through antigenic drift that diminish protection and re-entries from zoonotic reservoirs. Here we review relevant observations from previous epidemics and discuss the potential evolution of SARS-CoV-2 as it adapts during persistent transmission in the presence of a level of population immunity. Lack of effective surveillance or adequate response could enable the emergence of new epidemic or pandemic patterns from an endemic infection of SARS-CoV-2. There are key pieces of data that are urgently needed in order to make good decisions; we outline these and propose a way forward. More... »

PAGES

495-504

References to SciGraph publications

  • 2021-02-12. Humoral signatures of protective and pathological SARS-CoV-2 infection in children in NATURE MEDICINE
  • 2020-12-04. Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy in NATURE COMMUNICATIONS
  • 2021-02-26. SARS-CoV-2 spike D614G change enhances replication and transmission in NATURE
  • 2021-03-18. Five reasons why COVID herd immunity is probably impossible in NATURE
  • 2020-02-24. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses in NATURE MICROBIOLOGY
  • 2021-06-14. Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals in NATURE MEDICINE
  • 2021-03-08. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 in NATURE
  • 2021-05-24. The need for global access to biomedical innovations during pandemics in NATURE BIOTECHNOLOGY
  • 2021-07-14. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape in NATURE
  • 2021-03-04. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies in NATURE MEDICINE
  • 2021-04-01. Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination in NATURE REVIEWS IMMUNOLOGY
  • 2018-10-10. The phylogenomics of evolving virus virulence in NATURE REVIEWS GENETICS
  • 2021-02-09. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 in NATURE
  • 2020-07-08. SARS-CoV-2 is transmitted via contact and via the air between ferrets in NATURE COMMUNICATIONS
  • 2020-05-14. Infection of dogs with SARS-CoV-2 in NATURE
  • 2021-05-17. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection in NATURE MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41586-021-03792-w

    DOI

    http://dx.doi.org/10.1038/s41586-021-03792-w

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1139462448

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/34237771


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical Microbiology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "COVID-19", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "COVID-19 Vaccines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Evolution, Molecular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immune Evasion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunization Programs", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Influenza, Human", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pandemics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "SARS-CoV-2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Time Factors", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.214007.0", 
              "name": [
                "Vir Biotechnology, San Francisco, CA, USA", 
                "Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Telenti", 
            "givenName": "Amalio", 
            "id": "sg:person.01162002733.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002733.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Vir Biotechnology, San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.507173.7", 
              "name": [
                "Vir Biotechnology, San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Arvin", 
            "givenName": "Ann", 
            "id": "sg:person.0657717623.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657717623.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA", 
              "id": "http://www.grid.ac/institutes/grid.270240.3", 
              "name": [
                "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Corey", 
            "givenName": "Lawrence", 
            "id": "sg:person.015456006072.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015456006072.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.498378.9", 
              "name": [
                "Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Corti", 
            "givenName": "Davide", 
            "id": "sg:person.01340264536.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340264536.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA", 
              "id": "http://www.grid.ac/institutes/grid.4367.6", 
              "name": [
                "Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA", 
                "Department of Medicine, Washington University School of Medicine, St Louis, MO, USA", 
                "Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Diamond", 
            "givenName": "Michael S.", 
            "id": "sg:person.0757052535.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757052535.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.59734.3c", 
              "name": [
                "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA", 
                "Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA", 
                "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA", 
                "The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA", 
                "Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garc\u00eda-Sastre", 
            "givenName": "Adolfo", 
            "id": "sg:person.01370061066.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370061066.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA", 
              "id": "http://www.grid.ac/institutes/grid.265219.b", 
              "name": [
                "Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garry", 
            "givenName": "Robert F.", 
            "id": "sg:person.01051136257.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051136257.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia", 
              "id": "http://www.grid.ac/institutes/grid.1013.3", 
              "name": [
                "Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Holmes", 
            "givenName": "Edward C.", 
            "id": "sg:person.012501436222.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012501436222.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Vir Biotechnology, San Francisco, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.507173.7", 
              "name": [
                "Vir Biotechnology, San Francisco, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pang", 
            "givenName": "Phillip S.", 
            "id": "sg:person.011055512241.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011055512241.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA", 
              "id": "http://www.grid.ac/institutes/grid.267313.2", 
              "name": [
                "Vir Biotechnology, San Francisco, CA, USA", 
                "Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA", 
                "Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Virgin", 
            "givenName": "Herbert W.", 
            "id": "sg:person.01252531616.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252531616.22"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/s41586-021-03361-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135749813", 
              "https://doi.org/10.1038/s41586-021-03361-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-021-01263-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135363199", 
              "https://doi.org/10.1038/s41591-021-01263-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-021-01377-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1138107111", 
              "https://doi.org/10.1038/s41591-021-01377-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-021-01413-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1138847808", 
              "https://doi.org/10.1038/s41591-021-01413-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-021-03398-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1136211959", 
              "https://doi.org/10.1038/s41586-021-03398-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41577-021-00544-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1136840937", 
              "https://doi.org/10.1038/s41577-021-00544-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41576-018-0055-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107495951", 
              "https://doi.org/10.1038/s41576-018-0055-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41591-021-01294-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135910889", 
              "https://doi.org/10.1038/s41591-021-01294-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41564-020-0688-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1125089278", 
              "https://doi.org/10.1038/s41564-020-0688-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-021-03807-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1139689054", 
              "https://doi.org/10.1038/s41586-021-03807-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41467-020-20097-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1133087198", 
              "https://doi.org/10.1038/s41467-020-20097-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-021-03312-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1135284629", 
              "https://doi.org/10.1038/s41586-021-03312-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/d41586-021-00728-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1136475929", 
              "https://doi.org/10.1038/d41586-021-00728-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41587-021-00942-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1138291557", 
              "https://doi.org/10.1038/s41587-021-00942-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41467-020-17367-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1129065352", 
              "https://doi.org/10.1038/s41467-020-17367-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-020-2334-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1127597134", 
              "https://doi.org/10.1038/s41586-020-2334-5"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2021-07-08", 
        "datePublishedReg": "2021-07-08", 
        "description": "There is a realistic expectation that the global effort in vaccination will bring the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control. Nonetheless, uncertainties remain about the type of long-term association that the virus will establish with the human population and, in particular, whether coronavirus disease 2019 (COVID-19) will become an endemic disease. Although the trajectory is difficult to predict, the conditions, concepts and variables that influence this transition can be anticipated. Persistence of SARS-CoV-2 as an endemic virus, perhaps with seasonal epidemic peaks, may be fuelled by pockets of susceptible individuals and waning immunity after infection or vaccination, changes in the virus through antigenic drift that diminish protection and re-entries from zoonotic reservoirs. Here we review relevant observations from previous epidemics and discuss the potential evolution of SARS-CoV-2 as it adapts during persistent transmission in the presence of a level of population immunity. Lack of effective surveillance or adequate response could enable the emergence of new epidemic or pandemic patterns from an endemic infection of SARS-CoV-2. There are key pieces of data that are urgently needed in order to make good decisions; we outline these and propose a way forward.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41586-021-03792-w", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7873", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "596"
          }
        ], 
        "keywords": [
          "SARS-CoV-2", 
          "severe acute respiratory syndrome coronavirus 2", 
          "acute respiratory syndrome coronavirus 2", 
          "respiratory syndrome coronavirus 2", 
          "syndrome coronavirus 2", 
          "coronavirus disease 2019", 
          "coronavirus 2", 
          "population immunity", 
          "disease 2019", 
          "susceptible individuals", 
          "antigenic drift", 
          "endemic infection", 
          "pandemic patterns", 
          "epidemic peak", 
          "long-term association", 
          "zoonotic reservoirs", 
          "new epidemic", 
          "previous epidemics", 
          "endemic disease", 
          "effective surveillance", 
          "persistent transmission", 
          "COVID-19", 
          "vaccination", 
          "virus", 
          "infection", 
          "endemic viruses", 
          "immunity", 
          "realistic expectations", 
          "epidemic", 
          "adequate response", 
          "pandemic", 
          "disease", 
          "human population", 
          "global efforts", 
          "surveillance", 
          "association", 
          "population", 
          "individuals", 
          "response", 
          "levels", 
          "control", 
          "relevant observations", 
          "persistence", 
          "lack", 
          "transmission", 
          "changes", 
          "presence", 
          "protection", 
          "patterns", 
          "data", 
          "variables", 
          "pocket", 
          "types", 
          "potential evolution", 
          "efforts", 
          "emergence", 
          "observations", 
          "decisions", 
          "conditions", 
          "expectations", 
          "key piece", 
          "peak", 
          "perspective", 
          "trajectories", 
          "better decisions", 
          "reservoir", 
          "order", 
          "pieces", 
          "way", 
          "concept", 
          "transition", 
          "evolution", 
          "uncertainty", 
          "future trajectories", 
          "drift"
        ], 
        "name": "After the pandemic: perspectives on the future trajectory of COVID-19", 
        "pagination": "495-504", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1139462448"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41586-021-03792-w"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "34237771"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41586-021-03792-w", 
          "https://app.dimensions.ai/details/publication/pub.1139462448"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-08-04T17:10", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_887.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41586-021-03792-w"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41586-021-03792-w'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41586-021-03792-w'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41586-021-03792-w'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41586-021-03792-w'


     

    This table displays all metadata directly associated to this object as RDF triples.

    340 TRIPLES      21 PREDICATES      127 URIs      103 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41586-021-03792-w schema:about N195ac603f9f24a45b02c239c685ea563
    2 N48c487380f174043b97f58bff8bcf625
    3 N7b8b1d29dd37415e87299f95b6ae2c30
    4 N7cce6ec28ba34a9484441696634937cb
    5 N90df54ce0a224b70a00b51539660aefd
    6 N950c88273f374b8b9129267f08768ad2
    7 Nb493a5dc3c9b49ef9a95782656d3580b
    8 Nc5a8f6141aa7408fa8ce6f2c7e4dc171
    9 Ncb975a64710a40bb83a805405c40cdff
    10 Ncfbd63c581d74dd8b193ef1db8463230
    11 Ndaed3414538b4701ba834534abf03e39
    12 anzsrc-for:11
    13 anzsrc-for:1108
    14 schema:author Naf40b106504f42f29fac78cc296c22fe
    15 schema:citation sg:pub.10.1038/d41586-021-00728-2
    16 sg:pub.10.1038/s41467-020-17367-2
    17 sg:pub.10.1038/s41467-020-20097-0
    18 sg:pub.10.1038/s41564-020-0688-y
    19 sg:pub.10.1038/s41576-018-0055-5
    20 sg:pub.10.1038/s41577-021-00544-9
    21 sg:pub.10.1038/s41586-020-2334-5
    22 sg:pub.10.1038/s41586-021-03312-w
    23 sg:pub.10.1038/s41586-021-03361-1
    24 sg:pub.10.1038/s41586-021-03398-2
    25 sg:pub.10.1038/s41586-021-03807-6
    26 sg:pub.10.1038/s41587-021-00942-3
    27 sg:pub.10.1038/s41591-021-01263-3
    28 sg:pub.10.1038/s41591-021-01294-w
    29 sg:pub.10.1038/s41591-021-01377-8
    30 sg:pub.10.1038/s41591-021-01413-7
    31 schema:datePublished 2021-07-08
    32 schema:datePublishedReg 2021-07-08
    33 schema:description There is a realistic expectation that the global effort in vaccination will bring the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control. Nonetheless, uncertainties remain about the type of long-term association that the virus will establish with the human population and, in particular, whether coronavirus disease 2019 (COVID-19) will become an endemic disease. Although the trajectory is difficult to predict, the conditions, concepts and variables that influence this transition can be anticipated. Persistence of SARS-CoV-2 as an endemic virus, perhaps with seasonal epidemic peaks, may be fuelled by pockets of susceptible individuals and waning immunity after infection or vaccination, changes in the virus through antigenic drift that diminish protection and re-entries from zoonotic reservoirs. Here we review relevant observations from previous epidemics and discuss the potential evolution of SARS-CoV-2 as it adapts during persistent transmission in the presence of a level of population immunity. Lack of effective surveillance or adequate response could enable the emergence of new epidemic or pandemic patterns from an endemic infection of SARS-CoV-2. There are key pieces of data that are urgently needed in order to make good decisions; we outline these and propose a way forward.
    34 schema:genre article
    35 schema:isAccessibleForFree true
    36 schema:isPartOf N28cbe0eaad7d439389797a31aad6f12f
    37 N6ea1aa651bcb43bc9b965322f247409b
    38 sg:journal.1018957
    39 schema:keywords COVID-19
    40 SARS-CoV-2
    41 acute respiratory syndrome coronavirus 2
    42 adequate response
    43 antigenic drift
    44 association
    45 better decisions
    46 changes
    47 concept
    48 conditions
    49 control
    50 coronavirus 2
    51 coronavirus disease 2019
    52 data
    53 decisions
    54 disease
    55 disease 2019
    56 drift
    57 effective surveillance
    58 efforts
    59 emergence
    60 endemic disease
    61 endemic infection
    62 endemic viruses
    63 epidemic
    64 epidemic peak
    65 evolution
    66 expectations
    67 future trajectories
    68 global efforts
    69 human population
    70 immunity
    71 individuals
    72 infection
    73 key piece
    74 lack
    75 levels
    76 long-term association
    77 new epidemic
    78 observations
    79 order
    80 pandemic
    81 pandemic patterns
    82 patterns
    83 peak
    84 persistence
    85 persistent transmission
    86 perspective
    87 pieces
    88 pocket
    89 population
    90 population immunity
    91 potential evolution
    92 presence
    93 previous epidemics
    94 protection
    95 realistic expectations
    96 relevant observations
    97 reservoir
    98 respiratory syndrome coronavirus 2
    99 response
    100 severe acute respiratory syndrome coronavirus 2
    101 surveillance
    102 susceptible individuals
    103 syndrome coronavirus 2
    104 trajectories
    105 transition
    106 transmission
    107 types
    108 uncertainty
    109 vaccination
    110 variables
    111 virus
    112 way
    113 zoonotic reservoirs
    114 schema:name After the pandemic: perspectives on the future trajectory of COVID-19
    115 schema:pagination 495-504
    116 schema:productId N968d81ed67da443eb2a73b1b5f7f4c10
    117 N9d60cb42129f48889854d0346c0a3252
    118 N9e02241cd58d407ab456182127ca86ca
    119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1139462448
    120 https://doi.org/10.1038/s41586-021-03792-w
    121 schema:sdDatePublished 2022-08-04T17:10
    122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    123 schema:sdPublisher N0eb586f193524d519eb0606cc22b7856
    124 schema:url https://doi.org/10.1038/s41586-021-03792-w
    125 sgo:license sg:explorer/license/
    126 sgo:sdDataset articles
    127 rdf:type schema:ScholarlyArticle
    128 N097822f9a1e7498884484829016af0af rdf:first sg:person.01252531616.22
    129 rdf:rest rdf:nil
    130 N0eb586f193524d519eb0606cc22b7856 schema:name Springer Nature - SN SciGraph project
    131 rdf:type schema:Organization
    132 N195ac603f9f24a45b02c239c685ea563 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Animals
    134 rdf:type schema:DefinedTerm
    135 N28cbe0eaad7d439389797a31aad6f12f schema:volumeNumber 596
    136 rdf:type schema:PublicationVolume
    137 N48c487380f174043b97f58bff8bcf625 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Time Factors
    139 rdf:type schema:DefinedTerm
    140 N4b410db3446a4448810e2c99f9416106 rdf:first sg:person.01370061066.45
    141 rdf:rest Ne69235a44043422099217513361b440b
    142 N6ea1aa651bcb43bc9b965322f247409b schema:issueNumber 7873
    143 rdf:type schema:PublicationIssue
    144 N7904e4a57f224f60b1c46b486574882b rdf:first sg:person.011055512241.36
    145 rdf:rest N097822f9a1e7498884484829016af0af
    146 N7b8b1d29dd37415e87299f95b6ae2c30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name COVID-19 Vaccines
    148 rdf:type schema:DefinedTerm
    149 N7cce6ec28ba34a9484441696634937cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name SARS-CoV-2
    151 rdf:type schema:DefinedTerm
    152 N7f15420ac20c43ee844da028ca02b7d8 rdf:first sg:person.0657717623.97
    153 rdf:rest N85d79b0b4e6647b78e21e4ecc0548567
    154 N85d79b0b4e6647b78e21e4ecc0548567 rdf:first sg:person.015456006072.18
    155 rdf:rest Nee261c777065442dbb0de68ae29d45f7
    156 N90df54ce0a224b70a00b51539660aefd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Influenza, Human
    158 rdf:type schema:DefinedTerm
    159 N950c88273f374b8b9129267f08768ad2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Immunization Programs
    161 rdf:type schema:DefinedTerm
    162 N968d81ed67da443eb2a73b1b5f7f4c10 schema:name doi
    163 schema:value 10.1038/s41586-021-03792-w
    164 rdf:type schema:PropertyValue
    165 N9d60cb42129f48889854d0346c0a3252 schema:name dimensions_id
    166 schema:value pub.1139462448
    167 rdf:type schema:PropertyValue
    168 N9e02241cd58d407ab456182127ca86ca schema:name pubmed_id
    169 schema:value 34237771
    170 rdf:type schema:PropertyValue
    171 Na58cee8ecfce4a048f0dd9e3be9c6c17 rdf:first sg:person.012501436222.04
    172 rdf:rest N7904e4a57f224f60b1c46b486574882b
    173 Naf40b106504f42f29fac78cc296c22fe rdf:first sg:person.01162002733.02
    174 rdf:rest N7f15420ac20c43ee844da028ca02b7d8
    175 Nb493a5dc3c9b49ef9a95782656d3580b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Humans
    177 rdf:type schema:DefinedTerm
    178 Nc5a8f6141aa7408fa8ce6f2c7e4dc171 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name COVID-19
    180 rdf:type schema:DefinedTerm
    181 Ncb975a64710a40bb83a805405c40cdff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Pandemics
    183 rdf:type schema:DefinedTerm
    184 Ncfbd63c581d74dd8b193ef1db8463230 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Immune Evasion
    186 rdf:type schema:DefinedTerm
    187 Nd88653490b2b4dddad3f224b0998563c rdf:first sg:person.0757052535.15
    188 rdf:rest N4b410db3446a4448810e2c99f9416106
    189 Ndaed3414538b4701ba834534abf03e39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Evolution, Molecular
    191 rdf:type schema:DefinedTerm
    192 Ne69235a44043422099217513361b440b rdf:first sg:person.01051136257.59
    193 rdf:rest Na58cee8ecfce4a048f0dd9e3be9c6c17
    194 Nee261c777065442dbb0de68ae29d45f7 rdf:first sg:person.01340264536.63
    195 rdf:rest Nd88653490b2b4dddad3f224b0998563c
    196 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    197 schema:name Medical and Health Sciences
    198 rdf:type schema:DefinedTerm
    199 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
    200 schema:name Medical Microbiology
    201 rdf:type schema:DefinedTerm
    202 sg:journal.1018957 schema:issn 0028-0836
    203 1476-4687
    204 schema:name Nature
    205 schema:publisher Springer Nature
    206 rdf:type schema:Periodical
    207 sg:person.01051136257.59 schema:affiliation grid-institutes:grid.265219.b
    208 schema:familyName Garry
    209 schema:givenName Robert F.
    210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051136257.59
    211 rdf:type schema:Person
    212 sg:person.011055512241.36 schema:affiliation grid-institutes:grid.507173.7
    213 schema:familyName Pang
    214 schema:givenName Phillip S.
    215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011055512241.36
    216 rdf:type schema:Person
    217 sg:person.01162002733.02 schema:affiliation grid-institutes:grid.214007.0
    218 schema:familyName Telenti
    219 schema:givenName Amalio
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162002733.02
    221 rdf:type schema:Person
    222 sg:person.012501436222.04 schema:affiliation grid-institutes:grid.1013.3
    223 schema:familyName Holmes
    224 schema:givenName Edward C.
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012501436222.04
    226 rdf:type schema:Person
    227 sg:person.01252531616.22 schema:affiliation grid-institutes:grid.267313.2
    228 schema:familyName Virgin
    229 schema:givenName Herbert W.
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252531616.22
    231 rdf:type schema:Person
    232 sg:person.01340264536.63 schema:affiliation grid-institutes:grid.498378.9
    233 schema:familyName Corti
    234 schema:givenName Davide
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340264536.63
    236 rdf:type schema:Person
    237 sg:person.01370061066.45 schema:affiliation grid-institutes:grid.59734.3c
    238 schema:familyName García-Sastre
    239 schema:givenName Adolfo
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370061066.45
    241 rdf:type schema:Person
    242 sg:person.015456006072.18 schema:affiliation grid-institutes:grid.270240.3
    243 schema:familyName Corey
    244 schema:givenName Lawrence
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015456006072.18
    246 rdf:type schema:Person
    247 sg:person.0657717623.97 schema:affiliation grid-institutes:grid.507173.7
    248 schema:familyName Arvin
    249 schema:givenName Ann
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657717623.97
    251 rdf:type schema:Person
    252 sg:person.0757052535.15 schema:affiliation grid-institutes:grid.4367.6
    253 schema:familyName Diamond
    254 schema:givenName Michael S.
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757052535.15
    256 rdf:type schema:Person
    257 sg:pub.10.1038/d41586-021-00728-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136475929
    258 https://doi.org/10.1038/d41586-021-00728-2
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1038/s41467-020-17367-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129065352
    261 https://doi.org/10.1038/s41467-020-17367-2
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1038/s41467-020-20097-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1133087198
    264 https://doi.org/10.1038/s41467-020-20097-0
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/s41564-020-0688-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1125089278
    267 https://doi.org/10.1038/s41564-020-0688-y
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/s41576-018-0055-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107495951
    270 https://doi.org/10.1038/s41576-018-0055-5
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1038/s41577-021-00544-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136840937
    273 https://doi.org/10.1038/s41577-021-00544-9
    274 rdf:type schema:CreativeWork
    275 sg:pub.10.1038/s41586-020-2334-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1127597134
    276 https://doi.org/10.1038/s41586-020-2334-5
    277 rdf:type schema:CreativeWork
    278 sg:pub.10.1038/s41586-021-03312-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1135284629
    279 https://doi.org/10.1038/s41586-021-03312-w
    280 rdf:type schema:CreativeWork
    281 sg:pub.10.1038/s41586-021-03361-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1135749813
    282 https://doi.org/10.1038/s41586-021-03361-1
    283 rdf:type schema:CreativeWork
    284 sg:pub.10.1038/s41586-021-03398-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136211959
    285 https://doi.org/10.1038/s41586-021-03398-2
    286 rdf:type schema:CreativeWork
    287 sg:pub.10.1038/s41586-021-03807-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1139689054
    288 https://doi.org/10.1038/s41586-021-03807-6
    289 rdf:type schema:CreativeWork
    290 sg:pub.10.1038/s41587-021-00942-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1138291557
    291 https://doi.org/10.1038/s41587-021-00942-3
    292 rdf:type schema:CreativeWork
    293 sg:pub.10.1038/s41591-021-01263-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1135363199
    294 https://doi.org/10.1038/s41591-021-01263-3
    295 rdf:type schema:CreativeWork
    296 sg:pub.10.1038/s41591-021-01294-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1135910889
    297 https://doi.org/10.1038/s41591-021-01294-w
    298 rdf:type schema:CreativeWork
    299 sg:pub.10.1038/s41591-021-01377-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1138107111
    300 https://doi.org/10.1038/s41591-021-01377-8
    301 rdf:type schema:CreativeWork
    302 sg:pub.10.1038/s41591-021-01413-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1138847808
    303 https://doi.org/10.1038/s41591-021-01413-7
    304 rdf:type schema:CreativeWork
    305 grid-institutes:grid.1013.3 schema:alternateName Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia
    306 schema:name Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia
    307 rdf:type schema:Organization
    308 grid-institutes:grid.214007.0 schema:alternateName Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA
    309 schema:name Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA
    310 Vir Biotechnology, San Francisco, CA, USA
    311 rdf:type schema:Organization
    312 grid-institutes:grid.265219.b schema:alternateName Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA
    313 schema:name Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA
    314 rdf:type schema:Organization
    315 grid-institutes:grid.267313.2 schema:alternateName Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
    316 schema:name Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
    317 Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA
    318 Vir Biotechnology, San Francisco, CA, USA
    319 rdf:type schema:Organization
    320 grid-institutes:grid.270240.3 schema:alternateName Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    321 schema:name Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    322 rdf:type schema:Organization
    323 grid-institutes:grid.4367.6 schema:alternateName Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA
    324 schema:name Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
    325 Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA
    326 Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA
    327 rdf:type schema:Organization
    328 grid-institutes:grid.498378.9 schema:alternateName Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
    329 schema:name Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
    330 rdf:type schema:Organization
    331 grid-institutes:grid.507173.7 schema:alternateName Vir Biotechnology, San Francisco, CA, USA
    332 schema:name Vir Biotechnology, San Francisco, CA, USA
    333 rdf:type schema:Organization
    334 grid-institutes:grid.59734.3c schema:alternateName Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    335 schema:name Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    336 Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    337 Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    338 Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    339 The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    340 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...